AxoGen Losses Alert: Bernstein Liebhard LLP Announces First Investigation Of AxoGen, Inc. - AXGN

NEW YORK, Dec. 20, 2018

If you purchased AxoGen securities, and/or would like to discuss your legal rights and options, please visit AxoGen Shareholder Investigation or contact Daniel Sadeh toll free at (877) 779-1414 or dsadeh@bernlieb.com.

On December 18, 2018, Seligman Investments issued a report stating, among other things, that "[a] number of former [AxoGen] employees allege channel stuffing [at AxoGen], given that the company's consignment model creates potential for abuse, as well as alleging questionable revenue recognition practices." Further, the report states that "allegations additionally include misleading operating metrics, with one former rep implying that the company's definition of 'active accounts' may overstate the actual number by a factor of ten."

On this news, AxoGen's stock fell $6.17 per share or approximately 22% to close at $21.36 per share on December 18, 2018, damaging investors.

If you purchased AxoGen securities, and/or would like to discuss your legal rights and options, please visit https://www.bernlieb.com/cases/axogen-inc-axgn-lawsuit-class-action-fraud-stock-102/ or contact Daniel Sadeh toll free at (877) 779-1414 or dsadeh@bernlieb.com.

Since 1993, Bernstein Liebhard LLP has recovered over $3.5 billion for its clients. In addition to representing individual investors, the Firm has been retained by some of the largest public and private pension funds in the country to monitor their assets and pursue litigation on their behalf. As a result of its success litigating hundreds of lawsuits and class actions, the Firm has been named to The National Law Journal's "Plaintiffs' Hot List" thirteen times and listed in The Legal 500 for ten consecutive years.